FUZZY PREDICTION OF INCIPIENT ALZHEIMER’S DISEASE CASES FROM MILD COGNITIVE IMPAIRED CASES
暂无分享,去创建一个
[1] K. Jellinger. Diagnostic accuracy of Alzheimer’s disease: A clinicopathological study , 2009, Acta Neuropathologica.
[2] S. Gupta,et al. Toward a definite diagnosis of Alzheimer's disease. , 1992, Comprehensive psychiatry.
[3] Marina Spivak. Analysis of Mass Spectrometry Data for Protein Identification In Complex Biological Mixtures , 2010 .
[4] Andreas Quandt,et al. Finding regions of significance in SELDI measurements for identifying protein biomarkers , 2006, Bioinform..
[5] M. MacCoss,et al. A fast SEQUEST cross correlation algorithm. , 2008, Journal of proteome research.
[6] L A Hansen,et al. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. , 1994, Archives of neurology.
[7] Harald Hampel,et al. CSF total tau, Aβ42 and phosphorylated tau protein as biomarkers for Alzheimer’s disease , 2001, Molecular Neurobiology.
[8] J. Schneider,et al. Risk of incident clinical diagnosis of Alzheimer's disease–type dementia attributable to pathology-confirmed vascular disease , 2017, Alzheimer's & Dementia.
[9] Gautam B. Singh,et al. Classification by Clustering: Saliva MS-SELDI Data for Alzheimer's Disease Diagnosis , 2017, 2017 International Conference on Sensing, Diagnostics, Prognostics, and Control (SDPC).
[10] J. Yates,et al. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.
[11] K. Blennow,et al. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative , 2014, Alzheimer's & Dementia.